Ozempinomics

In this episode, Ariel breaks down how GLP-1s are reshaping the U.S. economy, inspired by a talk she attended at Aspen Ideas Health. After a quick history (yes, there’s a Gila monster involved), she covers who’s using GLP-1s, what they cost, and the ripple effects: smaller grocery bills, fewer food trucks on the road, potential airline fuel savings, a clothing-spending boom, and changes in how people work out. Mattie and Olivia share their own GLP-1 experiences along the way. This episode’s good news is that the CDC-funded hepatitis B birth dose study in Guinea-Bissau is officially dead, after the country’s leaders rejected it. Also, stick around to hear Mattie talk about Spooky Lake Month ~ Happy Halloween! Recalls: Find all recent recalls at: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts Mentioned in this episode: Aspen Ideas: Health GLP-1 Talk KFF Health Tracking Poll PwC GLP-1 Consumer Trends Report Gallup Poll NCSL on GLP-1 Access and Affordability 2025 Journal of Marketing Research Study 2026 Systematic Review, International Journal of Obesity Support the show Want to support PHGC?  Subscribe to our Patreon for monthly bonus episodes Donate as a supporter Snag some PHGC merch Give us a rating on Apple Podcasts or Spotify, and share this episode with a friend! --- The views expressed on this episode are our own. We are available by email at [email protected] and on Instagram and TikTok at @publichealthgroupchat. Theme music generated in Soundful.